Status:
COMPLETED
Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
Lead Sponsor:
Tehran University of Medical Sciences
Collaborating Sponsors:
Golestan University of Medical sciences
University of Birmingham
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The primary purpose of this study is to determine the effects of a fixed dose combination of valsartan, hydrochlorothiazide, atorvastatin and aspirin (PolyPill) on prevention of cardiovascular events ...
Detailed Description
2400 subjects will be randomly selected from participants of the Golestan Cohort Study (GCS) who are living in Gonbad and are over 50 years old. These subjects will be randomized to either receive Pol...
Eligibility Criteria
Inclusion
- \- Being enrolled in Golestan Cohort Study
Exclusion
- Debilitating disease causing inability to comply
- Contraindications to any of the components of PolyPill
- Not consenting to the study
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT01245608
Start Date
October 1 2011
End Date
September 1 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Golestan Cohort Center
Gonbad, Golestan Province, Iran